Provided by Tiger Trade Technology Pte. Ltd.

Iovance Biotherapeutics, Inc.

2.57
+0.04501.79%
Volume:2.93M
Turnover:7.51M
Market Cap:1.02B
PE:-2.14
High:2.60
Open:2.58
Low:2.52
Close:2.52
52wk High:8.15
52wk Low:1.64
Shares:396.97M
Float Shares:304.00M
Volume Ratio:0.99
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1987
EPS(LYR):-1.2839
ROE:-53.89%
ROA:-27.12%
PB:1.45
PE(LYR):-2.00

Loading ...

Iovance Biotherapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
21 hours ago

Iovance Biotherapeutics Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 24

Iovance Biotherapeutics (IOVA) Gets a Buy from Barclays

TIPRANKS
·
Nov 24

Iovance Biotherapeutics Grants Stock Options to New Employees Under Amended Inducement Plan

Reuters
·
Nov 22

Stock Track | Iovance Biotherapeutics Soars 5.65% Pre-Market Despite Mixed Goldman Sachs Report

Stock Track
·
Nov 10

Iovance Biotherapeutics price target raised to $1.50 from $1 at Goldman Sachs

TIPRANKS
·
Nov 10

Stock Track | Iovance Biotherapeutics Plummets 6.32% as Chardan Slashes Price Target

Stock Track
·
Nov 07

Stock Track | Iovance Biotherapeutics Plummets 6.32% as Chardan Slashes Price Target

Stock Track
·
Nov 07

Stock Track | Iovance Biotherapeutics Plunges 5.19% Pre-market Following Chardan's Price Target Cut

Stock Track
·
Nov 07

Chardan Cuts Price Target on Iovance Biotherapeutics to $17 From $20, Keeps Buy Rating

MT Newswires Live
·
Nov 07

Stock Track | Iovance Biotherapeutics Soars 6.93% on Strong Q3 Results and Revenue Growth

Stock Track
·
Nov 07

Iovance Biotherapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 07

Iovance Biotherapeutics Up Over 35%, on Pace for Largest Percent Increase Since May 2019 -- Data Talk

Dow Jones
·
Nov 07

Iovance Biotherapeutics (IOVA) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Nov 07

Stock Track | Iovance Biotherapeutics Soars 31.49% on Strong Q3 Results and Pipeline Progress

Stock Track
·
Nov 06

Iovance Biotherapeutics Showcases TIL Therapy Advances and Pipeline in New Corporate Presentation

Reuters
·
Nov 06

Stock Track | Iovance Biotherapeutics (IOVA) Surges 13.82% Pre-market on Strong Q3 Results and Revenue Growth

Stock Track
·
Nov 06

Stock Track | Iovance Biotherapeutics Soars 13.82% Pre-market on Strong Q3 Results and Revenue Growth

Stock Track
·
Nov 06

Iovance Biotherapeutics Q3 EPS $(0.25) Beats $(0.26) Estimate, Sales $67.455M Miss $72.402M Estimate

Benzinga
·
Nov 06

Iovance Biotherapeutics Reports 13% Revenue Growth and Improved Gross Margin in Q3 2025

Reuters
·
Nov 06